INDO-GLOBAL ENT. | THYROCARE TECHNOLOGIES | INDO-GLOBAL ENT./ THYROCARE TECHNOLOGIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | 61.1 | - | View Chart |
P/BV | x | 1.4 | 9.7 | 14.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO-GLOBAL ENT. THYROCARE TECHNOLOGIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
THYROCARE TECHNOLOGIES Mar-24 |
INDO-GLOBAL ENT./ THYROCARE TECHNOLOGIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 722 | 2.8% | |
Low | Rs | 20 | 430 | 4.7% | |
Sales per share (Unadj.) | Rs | 0 | 108.0 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 13.1 | -5.0% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 22.0 | -3.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 11.1 | 98.7 | 11.2% | |
Shares outstanding (eoy) | m | 6.37 | 52.95 | 12.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 5.3 | - | |
Avg P/E ratio | x | -31.1 | 43.9 | -70.9% | |
P/CF ratio (eoy) | x | -31.1 | 26.2 | -118.9% | |
Price / Book Value ratio | x | 1.8 | 5.8 | 31.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 130 | 30,493 | 0.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 1,079 | 0.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 5,719 | 0.0% | |
Other income | Rs m | 0 | 94 | 0.0% | |
Total revenues | Rs m | 0 | 5,812 | 0.0% | |
Gross profit | Rs m | -1 | 1,392 | -0.1% | |
Depreciation | Rs m | 0 | 470 | 0.0% | |
Interest | Rs m | 1 | 55 | 1.2% | |
Profit before tax | Rs m | -2 | 960 | -0.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 265 | 0.8% | |
Profit after tax | Rs m | -4 | 695 | -0.6% | |
Gross profit margin | % | 0 | 24.3 | - | |
Effective tax rate | % | -93.4 | 27.6 | -338.5% | |
Net profit margin | % | 0 | 12.2 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 2,785 | 0.0% | |
Current liabilities | Rs m | 7 | 905 | 0.8% | |
Net working cap to sales | % | 0 | 32.9 | - | |
Current ratio | x | 0 | 3.1 | 0.2% | |
Inventory Days | Days | 0 | 114 | - | |
Debtors Days | Days | 0 | 3 | - | |
Net fixed assets | Rs m | 80 | 3,506 | 2.3% | |
Share capital | Rs m | 64 | 530 | 12.0% | |
"Free" reserves | Rs m | 7 | 4,695 | 0.1% | |
Net worth | Rs m | 71 | 5,224 | 1.4% | |
Long term debt | Rs m | 2 | 109 | 2.2% | |
Total assets | Rs m | 80 | 6,291 | 1.3% | |
Interest coverage | x | -2.1 | 18.4 | -11.5% | |
Debt to equity ratio | x | 0 | 0 | 161.9% | |
Sales to assets ratio | x | 0 | 0.9 | 0.0% | |
Return on assets | % | -4.4 | 11.9 | -36.5% | |
Return on equity | % | -5.9 | 13.3 | -44.4% | |
Return on capital | % | -2.0 | 19.0 | -10.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0.9 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 51 | 0.0% | |
Fx inflow | Rs m | 0 | 16 | 0.0% | |
Fx outflow | Rs m | 0 | 51 | 0.0% | |
Net fx | Rs m | 0 | -35 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 1,676 | -0.1% | |
From Investments | Rs m | NA | -913 | -0.0% | |
From Financial Activity | Rs m | 1 | -848 | -0.2% | |
Net Cashflow | Rs m | 0 | -85 | -0.0% |
Indian Promoters | % | 2.8 | 71.1 | 4.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 16.7 | - | |
FIIs | % | 0.0 | 1.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 28.9 | 336.4% | |
Shareholders | 543 | 59,377 | 0.9% | ||
Pledged promoter(s) holding | % | 0.0 | 100.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS NARAYANA HRUDAYALAYA DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | THYROCARE TECHNOLOGIES |
---|---|---|
1-Day | -4.76% | -1.33% |
1-Month | 6.24% | 8.01% |
1-Year | -13.28% | 71.23% |
3-Year CAGR | -7.78% | -5.26% |
5-Year CAGR | -4.74% | 11.63% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the THYROCARE TECHNOLOGIES share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of THYROCARE TECHNOLOGIES the stake stands at 71.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of THYROCARE TECHNOLOGIES.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
THYROCARE TECHNOLOGIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of THYROCARE TECHNOLOGIES.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.